Postpartum human breast milk levels of neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9)/NGAL complex in normal and pregnancies complicated with insulin-dependent gestational diabetes mellitus. A prospective pilot case-control study.
Adult
Biomarkers
/ analysis
Breast Feeding
Case-Control Studies
Colostrum
/ metabolism
Diabetes Mellitus, Type 1
/ diagnosis
Diabetes, Gestational
/ diagnosis
Female
Humans
Infant, Newborn
Lipocalin-2
/ analysis
Matrix Metalloproteinase 9
/ analysis
Milk, Human
/ physiology
Pilot Projects
Postpartum Period
/ physiology
Pregnancy
Prospective Studies
MMP-9/NGAL complex
Milk
NGAL
diabetic pregnancy
lipocalin-2
Journal
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology
ISSN: 1364-6893
Titre abrégé: J Obstet Gynaecol
Pays: England
ID NLM: 8309140
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
30
7
2019
medline:
9
2
2021
entrez:
30
7
2019
Statut:
ppublish
Résumé
Neutrophil gelatinase-associated lipocalin (NGAL) and its complex with matrix metalloproteinase-9 (MMP-9) are present in a variety of human tissues and extracellular fluids. The aim of this pilot prospective case-control study was to detect NGAL and MMP-9/NGAL complex in human breast milk postpartum in women with normal and pregnancies that developed insulin-depended gestational diabetes mellitus (iGDM). We detected both biomarkers in human breast milk and concentrations were determined at the first day of colostrum secretion and two days after, in 22 normal pregnancies and 13 pregnancies with iGDM. Mean NGAL concentration decreased significantly from the first to the second sample, in both groups. Mean MMP-9/NGAL complex concentration decreased also significantly from the first to the second sample in normal pregnancies. Mean complex concentration was significantly higher in diabetic pregnancies compared to normal ones in the second sample.IMPACT STATEMENT
Identifiants
pubmed: 31353996
doi: 10.1080/01443615.2019.1628191
doi:
Substances chimiques
Biomarkers
0
LCN2 protein, human
0
Lipocalin-2
0
Matrix Metalloproteinase 9
EC 3.4.24.35
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM